Pharmacy News

Drug Delivery Systems

Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days

Articles(s): 1 - 7 of 7 Go To Page:

9/1/10 - pSivida Corp announces FDA priority review for Iluvien for diabetic macular edema

Drug delivery products company pSivida Corp stated on Tuesday that the US Food and Drug Administration has granted Priority Review status for the company's New Drug Application filed for Iluvien for the treatment diabetic macular edema. The notification was granted to the company's licensee, Alimera Sciences.

9/1/10 - Studies from University catholique of Louvain describe new findings in DNA research

New research, 'Hollow microneedle arrays for intradermal drug delivery and DNA electroporation,' is the subject of a report. "Microneedle array was used in combination with a vibratory inserter to disrupt the stratum corneum, thus piercing the skin.

8/31/10 - Alimera's Iluvien receives FDA priority review for DME treatment

Alimera Sciences, a biopharmaceutical company, has announced that the company's new drug application, or NDA, for Iluvien has been accepted for filing and granted priority review status by the FDA. Iluvien is the company's investigational, sustained drug delivery system that releases sub-microgram levels of fluocinolone acetonide for the treatment

8/31/10 - MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone Sublingual Film for Treatment of Opioid Dependence

WARREN, N.J., Aug. 31 MonoSol Rx, the developers of PharmFilm technology and a drug delivery company specializing in film pharmaceutical products, today announced that its partner, Reckitt Benckiser Pharmaceuticals Inc., a wholly-owned subsidiary of Reckitt Benckiser Group plc, has received approval from the U.S. Food and Drug Administration to m

8/31/10 - pSivida Announces Iluvien Receives FDA Priority Review for Treatment of Diabetic Macular Edema

pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has been notified that the U.S. Food and Drug Administration has granted Priority Review status for the New Drug Application filed for Iluvien for the treatment

8/30/10 - AUTOMATED DRUG PREPARATION APPARATUS INCLUDING AUTOMATED DRUG RECONSTITUTION

An automated medication preparation system for preparing a prescribed dosage of medication in a drug delivery device includes a plurality of stations for receiving, handling and processing the drug delivery device so that the prescribed dosage of medication is delivered to the drug delivery device and a transporting device that receives and holds m

8/30/10 - TRI-MOLECULAR COMPLEXES AND THEIR USE IN DRUG DELIVERY SYSTEMS

This invention relates to macromolecular complexes useful in drug delivery systems, specifically tri-molecular complexes made between a water-soluble polymer and an acid-insoluble polymer in presence of a bridging molecule. If you would like to purchase a copy of this patent, please call MicroPatent at 800-648-6787.

Articles(s): 1 - 7 of 7 Go To Page: